VX-828

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Cystic Fibrosis

Phase 1

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

CompletedNCT06154447

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2023-12-12End: 2026-07-10Updated: 2026-08-10

A Phase 1 Study to Evaluate the Relative Bioavailability of a VX-828 Tablet Formulation

CompletedNCT06861413

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2025-04-01End: 2025-05-05Updated: 2025-06-04